Author: Schmidt, V; Blum, R; Möhrenschlager, M
Title: Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy Cord-id: bhomqc9p Document date: 2021_1_1
ID: bhomqc9p
Snippet: bullous pemphigoid (BP) is an autoimmune blistering disorder mainly affecting elderly people. Possible triggers associated with onset of BP lesions include drugs, infections, physical factors, and vaccinations.1 We report the case of an 84-year-old female who presented with severe itching and an erythematous rash for 10 weeks, starting at her back. Since four weeks, an additional eruption of blisters was noticed affecting arms, legs, and trunk. A few days prior to the onset of the rash, she had
Document: bullous pemphigoid (BP) is an autoimmune blistering disorder mainly affecting elderly people. Possible triggers associated with onset of BP lesions include drugs, infections, physical factors, and vaccinations.1 We report the case of an 84-year-old female who presented with severe itching and an erythematous rash for 10 weeks, starting at her back. Since four weeks, an additional eruption of blisters was noticed affecting arms, legs, and trunk. A few days prior to the onset of the rash, she had received her first dose of mRNA-1273 (Moderna, USA). A second dose was given 29 days later, which resulted in an increase of itching as well as area affected by the rash, and eruption of blisters.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date